ARTICLE | Company News
Biocortech SAS, Columbia University deal
February 27, 2006 8:00 AM UTC
Biocortech and the university partnered to study how differential mRNA editing of the serotonin (5-HT2C) receptor affects depression. The deal combines Biocortech's technology for generating editing ...